Invesaro

Stocks LTRN Earnings

Earnings

Lantern Pharma Inc. (LTRN) earnings

Quarterly results of Lantern Pharma Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when LTRN files with the SEC.

Next earnings date

Lantern Pharma Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Lantern Pharma Inc. reported revenue of - and a net loss of $7.1M.

Diluted earnings per share were -$0.57.

Filed with the SEC on August 14, 2026.

Net income by quarter
Q3 24: -$4.5M -$4.5M Q3 24Q4 24: -$5.9M -$5.9M Q4 24Q1 25: -$4.5M -$4.5M Q1 25Q2 25: -$4.3M -$4.3M Q2 25Q3 25: -$4.2M -$4.2M Q3 25Q4 25: -$4.1M -$4.1M Q4 25Q1 26: -$3.3M -$3.3M Q1 26Q2 26: -$7.1M -$7.1M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026---$7.1M-$0.57
Q1 FY2026March 31, 2026---$3.3M-$0.30
Q4 FY2025December 31, 2025---$4.1M-
Q3 FY2025September 30, 2025---$4.2M-$0.39
Q2 FY2025June 30, 2025---$4.3M-$0.40
Q1 FY2025March 31, 2025---$4.5M-$0.42
Q4 FY2024December 31, 2024---$5.9M-
Q3 FY2024September 30, 2024---$4.5M-$0.42

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Lantern Pharma Inc.'s next earnings date?

Lantern Pharma Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when LTRN reports

Follow LTRN and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when LTRN files with the SEC.

Source: quarterly figures Lantern Pharma Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Lantern Pharma Inc.